Cybin (NYSE:CYBN – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a ...

Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on ATAI Life Sciences (ATAI – Research Report). The associated ...

The research found that these compounds undergo dehydration through ... Research on ethylene glycol and its deuterated derivative further illustrates the impact of radiation on organic molecules.

It makes the case that the '335 patent covers claims on deuterated forms of the compound – a modification used to improve pharmacokinetic properties – that are infringed by Sun Pharma's compound.

1 Day CYBN -4.39% DJIA 0.65% Russell 2K -1.03% Health Care/Life Sciences -0.52% ...

Pre-Market: 5:17:47 a.m. EST ...

After hours: January 24 at 7:55:59 p.m. EST Loading Chart for ATAI ...